Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review
As Psycheceutical prepares to begin clinical trials for its novel NeuroDirect™ ketamine topical to treat PTSD, the company is named to Life Science Reviews yearly Top Biotech Start-Up... | April 13, 2023
United States Kaia Roman Rick Doblin Doblin Psycheceutical Strategy Communications Psycheceutical Inc
Source: marketscreener.com